Olema Pharmaceuticals' Series A Round

Olema Pharmaceuticals raised a round of funding on August 27, 2018.

Olema Pharmaceuticals, fka CombiThera, is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer.…

Articles about Olema Pharmaceuticals' Series A Round: